COLL News and Press, Collegium Pharmaceutical Inc. From 02/14/22

InvestorPlace - Stock Market News, Stock Advice & Trading Tips One of the biggest movers in today’s market is BioDelivery Sciences (NASDAQ: BDSI ). At the time of writing, BDSI stock has surged more than 50% higher on incredible volume. This move comes, as many would expec...

Collegium Pharmaceutical, Inc. (NASDAQ: COLL) and BioDelivery Sciences International Inc. (NASDAQ: BDSI) have announced a definitive agreement where Collegium will acquire BDSI for USD 5.60 per share in cash.  BDSI holds a portfolio of pain and neurology products ...

Buying Penny Stocks Today? Here’s What You Need to Know With another week of trading penny stocks and blue chips here, there is a lot for investors to know. Now, it can be challenging to make money with penny stocks in 2022 given the sheer amount of information and news that ...

Transaction is valued at $5.60 per share representing a total equity value of $604 million Represents a 54% premium to BDSI stock’s closing price of $3.64 on February 11, 2022 and a 65% premium to the 30 trading days volume weighted average price of $3.40 Transactio...

- Expected to be Immediately and Highly Accretive Driven by Identified Annual Synergies of at Least $75 Million - - Will Diversify Revenue Growth and Accelerate Cash Flow Generation - - Addition of BELBUCA ® Provides a Second Growth Driver and ELYXYB...

STOUGHTON, Mass., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that the Company will host a conference call and live audio webcast on Thursday, February 24, 2022, at 4:30 p.m. Eastern Time. The Company will discuss its fourth quarter an...

Collegium Pharmaceutical (NASDAQ:COLL) announces a settlement framework to resolve 27 pending opioid-related lawsuits brought against the firm by cities, counties, and other subdivisions in the U.S. The firm will pay up to $2.75M in exchange for the dismissal, with prejudice, of the...

STOUGHTON, Mass., Dec. 28, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced the execution of a settlement framework to resolve all 27 pending opioid-re...

Pharma/biotech is the most attractive subsector. The most overvalued one is life science tools. IXJ: an alternative to XLV. 10 stocks cheaper than their peers in December. For further details see: IXJ: Healthcare Dashboard For December

STOUGHTON, Mass., Dec. 06, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that it has been named one of the Top Places to Work in Massachusetts in ...